The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations

Current Cardiology Reports

Volumn 10, Issue 2, 2008, Pages 149-157

  Dickfeld, Timm ^a   Kocher, Christopher ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPATHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; ELECTRIC POTENTIAL; EPICARDIUM MAPPING; FOLLOW UP; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; IMAGE ANALYSIS; MYOCARDIAL HIBERNATION; MYOCARDIAL SCAR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOFREQUENCY ABLATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CATHETER ABLATION; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; INSTRUMENTATION; PATHOPHYSIOLOGY; RADIOGRAPHY; THREE DIMENSIONAL IMAGING;

BODY SURFACE POTENTIAL MAPPING; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTROPHYSIOLOGY; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; TACHYCARDIA, VENTRICULAR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 44449089497     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-008-0025-1     Document Type: Review

References (54)

1. McCullough PA, Philbin EF, Spertus JA, et al.: Confirmation of a heart failure epidemic: Findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002, 39:60-69.
2. Redfield MM: Heart failure - an epidemic of uncertain proportions. N Engl J Med 2002, 347:1442-1444.
3. Bardy GH, Lee KL, Mark DB, et al.: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352:225-237.
4. Moss AJ, Zareba W, Hall WJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883.
5. Morady F, Harvey M, Kalbfleisch SJ, et al.: Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation 1993, 87:363-372.
6. Stevenson WG, Khan H, Sager P, et al.: Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993, 88:1647-1670.
7. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E: Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000, 101:1288-1296.
8. Hunold P, Schlosser T, Vogt FM, et al.: Myocardial late enhancement in contrast-enhanced cardiac MRI: Distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol 2005, 184:1420-1426.
9. de Bakker JM, van Capelle FJ, Janse MJ, et al.: Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 1988, 77:589-606.
10. de Bakker JM, van Capelle FJ, Janse MJ, et al.: Slow conduction in the infarcted human heart. 'Zigzag' course of activation. Circulation 1993, 88:915-926.
11. Nazarian S, Bluemke DA, Lardo AC, et al.: Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005, 112:2821-2825.
12. Stevenson WG, Friedman PL, Kocovic D, et al.: Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation 1998, 98:308-314.
13. Oza S, Wilber DJ: Substrate-based endocardial ablation of postinfarction ventricular tachycardia. Heart Rhythm 2006, 3:607-609.
14. Verma A, Marrouche NF, Schweikert RA, et al.: Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia post-myocardial infarction. J Cardiovasc Electrophysiol 2005, 16:465-471.
15. Gepstein L, Hayam G, Ben Haim SA: A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation 1997, 95:1611-1622.
16. Kim RJ, Fieno DS, Parrish TB, et al.: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992-2002.
17. Lima JA, Judd RM, Bazille A, et al.: Regional heterogeneity of human myocardial infarcts demonstrated by contrastenhanced MRI. Potential mechanisms. Circulation 1995, 92:1117-1125.
18. Rehwald WG, Fieno DS, Chen EL, et al.: Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002, 105:224-229.
19. Faris OP, Shein M: Food and Drug AdmMnistration perspective: magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation 2006, 114:1232-1233.
20. Marckmann P, Skov L, Rossen K, et al.: Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006, 17:2359-2362.
21. Lardo AC, Cordeiro MA, Silva C, et al.: Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation 2006, 113:394-404.
22. Mahnken AH, Koos R, Katoh M, et al.: Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol 2005, 45:2042-2047.
23. Brunken R, Tillisch J, Schwaiger M, et al.: Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: Evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986, 73:951-963.
24. Maes A, Flameng W, Nuyts J, et al.: Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994, 90:735-745.
25. Tamaki N, Kawamoto M, Tadamura E, et al.: Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. Circulation 1995, 91:1697-1705.
26. Yoshida K, Gould KL: Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. J Am Coll Cardiol 1993, 22:984-997.
27. Jain D, Strauss HW: Principles of cardiovascular imaging. In Atlas of Nuclear Cardiology. Edited by Dilsizian V, Narula J. Philadelphia: Current Medicine; 2003:1-19.
28. Chareonthaitawee P, Schaefers K, Baker CS, et al.: Assessment of infarct size by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose: A new absolute threshold technique. Eur J Nucl Med Mol Imaging 2002, 29:203-215.
29. Higuchi T, Nekolla SG, Jankaukas A, et al.: Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI. J Nucl Med 2007, 48:288-294.
30. Berry JJ, Hoffman JM, Steenbergen C, et al.: Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy. J Nucl Med 1993, 34:39-47.
31. Kuhl HP, Beek AM, van der Weerdt AP, et al.: Myocardial viability in chronic ischemic heart disease: Comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2003, 41:1341-1348.
32. Kornowski R, Hong MK, Leon MB: Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability. Circulation 1998, 98:1837-1841.
33. Gyongyosi M, Sochor H, Khorsand A, et al.: Online myocardial viability assessment in the catheterization laboratory via NOGA electroanatomic mapping: Quantitative comparison with thallium-201 uptake. Circulation 2001, 104:1005-1011.
34. Fuchs S, Hendel RC, Baim DS, et al.: Comparison of endocardial electromechanical mapping with radionuclide perfusion imaging to assess myocardial viability and severity of myocardial ischemia in angina pectoris. Am J Cardiol 2001, 87:874-880.
35. Gyongyosi M, Khorsand A, Sochor H, et al.: Characterization of hibernating myocardium with NOGA electroanatomic endocardial mapping. Am J Cardiol 2005, 95:722-728.
36. Koch KC, Vom DJ, Wenderdel M, et al.: Myocardial viability assessment by endocardial electroanatomic mapping: Comparison with metabolic imaging and functional recovery after coronary revascularization. J Am Coll Cardiol 2001, 38:91-98.
37. Botker HE, Lassen JF, Hermansen F, et al.: Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy. Circulation 2001, 103:1631-1637.
38. Keck A, Hertting K, Schwartz Y, et al.: Electromechanical mapping for determination of myocardial contractility and viability. A comparison with echocardiography, myocardial single-photon emission computed tomography, and positron emission tomography. J Am Coll Cardiol 2002, 40:1067-1074.
39. Wiggers H, Botker HE, Sogaard P, et al.: Electromechanical mapping versus positron emission tomography and single photon emission computed tomography for the detection of myocardial viability in patients with ischemic cardiomyopathy. J Am Coll Cardiol 2003, 41:843-848.
40. Callans DJ, Ren JF, Michele J, et al.: Electroanatomic left ventricular mapping in the porcine model of healed anterior myocardial infarction. Correlation with intracardiac echocardiography and pathological analysis. Circulation 1999, 100:1744-1750.
41. Gepstein L, Goldin A, Lessick J, et al.: Electromechanical characterization of chronic myocardial infarction in the canine coronary occlusion model. Circulation 1998, 98:2055-2064.
42. Kornowski R, Hong MK, Gepstein L, et al.: Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation 1998, 98:1116-1124.
43. Shekhar R, Walimbe V, Raja S, et al.: Automated 3-dimensional elastic registration of whole-body PET and CT from separate or combined scanners. J Nucl Med 2005, 46:1488-1496.
44. Francone M, Carbone I, Danti M, et al.: ECG-gated multidetector row spiral CT in the assessment of myocardial infarction: Correlation with non-invasive angiographic findings. Eur Radiol 2006, 16:15-24.
45. Nieman K, Cury RC, Ferencik M, et al.: Differentiation of recent and chronic myocardial infarction by cardiac computed tomography. Am J Cardiol 2006, 98:303-308.
46. Lessick J, Mutlak D, Rispler S, et al.: Comparison of multidetector computed tomography versus echocardiography for assessing regional left ventricular function. Am J Cardiol 2005, 96:1011-1015.
47. Gerber BL, Belge B, Legros GJ, et al.: Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation 2006, 113:823-833.
48. Di Carli MF, Dorbala S, Meserve J, et al.: Clinical myocardial perfusion PET/CT. J Nucl Med 2007, 48:783-793.
49. Dickfeld T, Calkins H, Zviman M, et al.: Anatomic stereotactic catheter ablation on three-dimensional magnetic resonance images in real time. Circulation 2003, 108:2407-2413.
50. Dong J, Calkins H, Solomon SB, et al.: Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations. Circulation 2006, 113:186-194.
51. Dong J, Dickfeld T, Dalal D, et al.: Initial experience in the use of integrated electroanatomic mapping with three-dimensional MR/CT images to guide catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2006, 17:459-466.
52. Dickfeld T, Lodge M, Voudouris A, et al.: Anatomic-metabolic scar imaging with positron emission tomography for guidance of ventricular tachycardia ablations. Heart Rhythm 2006, 3(1S):S74.
53. Dickfeld T, Voudouris A, Jeudy J, et al.: Fusion imaging with positron emission tomography/computer tomography (PET/CT) to guide ventricular tachycardia ablations. Circulation 2006, 114:3096.
54. Dickfeld T, Lei P, Dilsizian V, et al.: Integration of three-dimensional scar maps for ventricular tachycardia ablation with positron emission tomography-computed tomography. J Am Coll Cardiol 2008, In press.